[go: up one dir, main page]

ZA807716B - Controlled release compositions - Google Patents

Controlled release compositions

Info

Publication number
ZA807716B
ZA807716B ZA00807716A ZA807716A ZA807716B ZA 807716 B ZA807716 B ZA 807716B ZA 00807716 A ZA00807716 A ZA 00807716A ZA 807716 A ZA807716 A ZA 807716A ZA 807716 B ZA807716 B ZA 807716B
Authority
ZA
South Africa
Prior art keywords
controlled release
release compositions
compositions
controlled
release
Prior art date
Application number
ZA00807716A
Other languages
English (en)
Inventor
S Leslie
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of ZA807716B publication Critical patent/ZA807716B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/05—Alcohols; Metal alcoholates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
ZA00807716A 1979-12-19 1980-12-09 Controlled release compositions ZA807716B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE2480/79A IE49324B1 (en) 1979-12-19 1979-12-19 Controlled release compositions
IE248179 1979-12-19

Publications (1)

Publication Number Publication Date
ZA807716B true ZA807716B (en) 1981-12-30

Family

ID=26319271

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00807716A ZA807716B (en) 1979-12-19 1980-12-09 Controlled release compositions

Country Status (27)

Country Link
US (1) US4366310A (xx)
EP (1) EP0032004B1 (xx)
JP (1) JPS5698201A (xx)
AU (1) AU541246B2 (xx)
BE (1) BE886711A (xx)
CA (1) CA1168230A (xx)
CS (1) CS228142B2 (xx)
DE (1) DE3048028A1 (xx)
DK (1) DK170347B1 (xx)
EG (1) EG14984A (xx)
ES (1) ES8303489A1 (xx)
FI (1) FI66623C (xx)
FR (1) FR2474507B1 (xx)
GB (1) GB2067569B (xx)
GR (1) GR72265B (xx)
HU (1) HU188085B (xx)
IE (1) IE49324B1 (xx)
IL (1) IL61677A (xx)
MX (1) MX158088A (xx)
NL (1) NL187401C (xx)
NO (1) NO152846C (xx)
NZ (1) NZ195793A (xx)
PL (1) PL133079B1 (xx)
PT (1) PT72214B (xx)
SU (1) SU1178326A3 (xx)
YU (1) YU40957B (xx)
ZA (1) ZA807716B (xx)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1211266A (en) * 1982-11-12 1986-09-16 Alfred E. Lauchenauer Shaped semi-solid articles
DE3306621A1 (de) * 1983-02-25 1984-08-30 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von celluloseethern mit einem dimethoxyethan enthaltenden dispergierhilfsmittel
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
ATE107857T1 (de) * 1986-06-10 1994-07-15 Euro Celtique Sa Zusammensetzung mit kontrollierter freisetzung von dihydrocodein.
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US5023080A (en) * 1988-06-17 1991-06-11 Basic Bio Systems, Inc. Time release protein
US5079005A (en) * 1988-06-17 1992-01-07 Gupta Kashmiri L Time release protein
US5055300A (en) * 1988-06-17 1991-10-08 Basic Bio Systems, Inc. Time release protein
US5476668A (en) * 1990-08-24 1995-12-19 Shin-Etsu Chemical Co., Ltd. Base for film-coating pharmaceuticals and method for preparing same
IL109460A (en) 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
AU8532798A (en) * 1997-06-13 1998-12-30 Roland Bodmeier Compounds which delay the release of active substances
NZ505193A (en) 1997-12-22 2003-03-28 Euro Celtique S Opioid agonist/antagonist combinations
DK2517710T3 (en) 2000-02-08 2015-05-26 Euro Celtique Sa Oral opioid agonist formulations secured against forgery
ES2361148T3 (es) 2001-05-11 2011-06-14 Endo Pharmaceuticals Inc. Forma de dosificación de opioides de liberación controlada resistente al abuso.
WO2003007802A2 (en) 2001-07-18 2003-01-30 Euro-Celtique, S.A. Pharmaceutical combinations of oxycodone and naloxone
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
WO2003013525A1 (en) 2001-08-06 2003-02-20 Euro-Celtique S.A. Opioid agonist formulations with releasable and sequestered antagonist
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
AU2002324624A1 (en) 2001-08-06 2003-02-24 Euro-Celtique S.A. Sequestered antagonist formulations
PT1492505E (pt) 2002-04-05 2015-10-06 Euro Celtique Sa Preparação farmacêutica contendo oxicodona e naloxona
EP2422772A3 (en) 2002-09-20 2012-04-18 Alpharma, Inc. Sequestering subunit and related compositions and methods
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
CA2569958C (en) 2004-06-12 2016-03-22 Jane C. Hirsh Abuse-deterrent drug formulations
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
NZ573757A (en) 2006-06-19 2011-11-25 Alpharma Inc Coated multilayer oral dosage forms of naltrexone hydrochloride
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
JP2010159364A (ja) * 2009-01-09 2010-07-22 Kyoto Univ セルロースの高温での着色を抑制する方法
AU2010223323B2 (en) 2009-03-10 2013-07-04 Euro-Celtique S.A. Immediate release pharmaceutical compositions comprising oxycodone and naloxone
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
EP2568965A1 (en) 2010-05-10 2013-03-20 Euro-Celtique S.A. Combination of active loaded granules with additional actives
AU2011252039B2 (en) 2010-05-10 2014-06-12 Euro-Celtique S.A. Pharmaceutical compositions comprising hydromorphone and naloxone
BR112012028788A2 (pt) * 2010-05-10 2016-07-19 Euro Celtique Sa fabricação de grânulos sem ativos
MX367010B (es) 2010-12-22 2019-08-02 Purdue Pharma Lp Formas de dosis de liberacion controlada encerradas resistentes a manipulaciones indebidas.
PH12013501345A1 (en) 2010-12-23 2022-10-24 Purdue Pharma Lp Tamper resistant solid oral dosage forms
CN105120846B (zh) 2013-02-05 2019-10-18 普渡制药公司 抗篡改的药物制剂
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
EP3024461B1 (en) 2013-07-23 2020-05-13 Euro-Celtique S.A. A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
KR20160060768A (ko) 2013-11-13 2016-05-30 유로-셀티큐 에스.에이. 통증 및 오피오이드 장 기능장애 증후군의 치료를 위한 히드로모르폰 및 날록손
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264766A (en) * 1877-09-19 1981-04-28 Hoffmann-La Roche Inc. Immunological diagnostic reagents
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
GB1405088A (en) * 1971-06-03 1975-09-03 Mundipharma Ag Slow release formulation
US3988482A (en) * 1971-08-27 1976-10-26 Toyo Hakka Kogyo Kabushiki Kaisha Menthol glycoside, process for preparing the same and method for releasing menthol therefrom
US3818107A (en) * 1972-09-28 1974-06-18 Brook D Chewing gum with sustained flavor release compositions
US3899439A (en) * 1973-03-12 1975-08-12 Hercules Inc Method of preparing aqueous dispersions of hydroxypropyl cellulose
DE2644678A1 (de) * 1976-10-02 1978-04-06 Dynamit Nobel Ag Verfahren zur herstellung funktionalisierter cellulosen
JPS54105223A (en) * 1977-12-29 1979-08-18 Yamanouchi Pharmaceut Co Ltd Coating agent for solid medicine
US4259355A (en) * 1979-03-05 1981-03-31 International Flavors & Fragrances Inc. Chewing gum containing flavor composition and flavor composition therefor
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals

Also Published As

Publication number Publication date
IL61677A0 (en) 1981-01-30
HU188085B (en) 1986-03-28
MX158088A (es) 1989-01-06
NZ195793A (en) 1982-09-14
PT72214B (en) 1981-11-02
HUT34891A (en) 1985-05-28
JPH0225921B2 (xx) 1990-06-06
NO152846C (no) 1985-11-27
AU541246B2 (en) 1985-01-03
FR2474507B1 (fr) 1986-12-26
DE3048028A1 (de) 1981-09-10
PL133079B1 (en) 1985-05-31
FR2474507A1 (fr) 1981-07-31
GB2067569B (en) 1983-09-01
IE792480L (en) 1981-06-19
NL187401B (nl) 1991-04-16
EP0032004A2 (en) 1981-07-15
ES497906A0 (es) 1983-02-01
FI803848L (fi) 1981-06-20
YU321080A (en) 1983-06-30
ES8303489A1 (es) 1983-02-01
NO803836L (no) 1981-06-22
BE886711A (fr) 1981-06-17
AU6529880A (en) 1981-06-25
FI66623C (fi) 1984-11-12
EP0032004B1 (en) 1985-05-15
NL187401C (nl) 1991-09-16
PT72214A (en) 1980-08-01
IL61677A (en) 1984-10-31
US4366310A (en) 1982-12-28
NL8006891A (nl) 1981-07-16
SU1178326A3 (ru) 1985-09-07
EG14984A (en) 1986-06-30
JPS5698201A (en) 1981-08-07
NO152846B (no) 1985-08-19
DK170347B1 (da) 1995-08-07
EP0032004A3 (en) 1982-07-14
PL228573A1 (xx) 1982-07-19
CS228142B2 (en) 1984-05-14
CA1168230A (en) 1984-05-29
IE49324B1 (en) 1985-09-18
GR72265B (xx) 1983-10-10
YU40957B (en) 1986-08-31
DK527680A (da) 1981-08-05
FI66623B (fi) 1984-07-31
GB2067569A (en) 1981-07-30

Similar Documents

Publication Publication Date Title
EG14984A (en) Controlled release compositions
GB2056278B (en) Sustained release compositions
DE3068218D1 (en) Controlled release formulations
GB2046283B (en) Soloxane composition
JPS565899A (en) Claning composition
JPS5634751A (en) Polycarbonateepolyolefin composition
JPS55129447A (en) Composition
JPS5682839A (en) Waterrabsorbable composition
GB2059766B (en) Controlled release formulations
EG15103A (en) Oxytetrocycline compositions
IE800872L (en) Tickicidal compositions
JPS5691075A (en) Size composition
GB2063348B (en) Release mechanism
JPS5622734A (en) Composition
JPS5649747A (en) Ureaaformaldehyde composition
JPS56135531A (en) Composition
JPS55118957A (en) Flameeproof composition
GB2058034B (en) Fluocculant composition
ZA805153B (en) Schistosomididal compositions
ZA803634B (en) Water-settable compositions
GB2062462B (en) Compositions phthalazinol
JPS5655393A (en) Hydrocarbonnsoluble magnesiummaluminum composition
JPS55157694A (en) Clensing composition
EG14325A (en) Pesticidel compositions
ZA801365B (en) Controlled release graunules